The M815 utilises Microfluidizer® proprietary high shear fluid processing technology for uniform droplet and particle size reduction, which enables the production of stable nanoemulsions, nanosuspensions, liposomes and the nanoencapsulation of actives. Additionally, Microfluidizer® technology offers the most efficient method for disruption of yeast, E. coli, plant and mammalian cells.
Like all Microfluidizer processors, the M815 utilises the fixed-geometry interaction chamber and constant pressure pumping system. This technology allows users to achieve smaller particle sizes – with more uniform distribution and scale-up guaranteed (both from lab scale and to larger scale units) – than can be obtained with other methods.
The M815 models are designed to bridge the gap between the biopharma lab scale (M-100EH) and production scale (M-700 Series) models, and they are ideal for manufacturing batches in the range of 100L-300L, which are necessary for PHII and PHIII clinical trials.
The M815 model was designed to bridge the gap between the lab scale (M-110EH) and production scale (M-700 series) models, and they are ideal for manufacturing batches in the range of 100L-300L.
up to 30,000 psi (2068 bar)
1.0 – 1.2 L/min
W x D x H
|57″L x 34″W x 72″H
(145 x 86 x 183 cm)
1,950 lbs (886 kg) with oil
1800 lbs (818kg) without oil
Interested in the M-815 Microfluidizer® Processor? Request a quote or call us on +44(0)1954 232 776 to discuss your requirements.